Bruker Corporation (NASDAQ:BRKR) Receives $57.00 Consensus Target Price from Brokerages

Bruker Corporation (NASDAQ:BRKR) has been given an average recommendation of “Hold” by the fourteen analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $57.00.

Several brokerages have issued reports on BRKR. Stifel Nicolaus set a $50.00 target price on Bruker in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Bruker in a research report on Monday, August 31st. JPMorgan Chase & Co. increased their price objective on shares of Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a research note on Monday, June 8th. UBS Group began coverage on shares of Bruker in a report on Wednesday, September 9th. They issued a “neutral” rating and a $65.00 price objective on the stock. Finally, Zacks Research lowered shares of Bruker from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 2nd.

Insider Activity

In other news, VP Mark Munch sold 2,000 shares of the business’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total transaction of $105,740.00. Following the completion of the sale, the vice president owned 134,806 shares of the company’s stock, valued at $7,127,193.22. The trade was a 1.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 27.20% of the stock is currently owned by insiders.

Institutional Trading of Bruker

Several hedge funds have recently bought and sold shares of BRKR. Sequoia Financial Advisors LLC purchased a new stake in Bruker in the second quarter worth about $250,000. Tidal Investments LLC raised its stake in shares of Bruker by 180.4% in the second quarter. Tidal Investments LLC now owns 29,092 shares of the medical research company’s stock worth $1,751,000 after buying an additional 18,715 shares during the period. WINTON GROUP Ltd purchased a new position in shares of Bruker during the 2nd quarter valued at about $344,000. Engineers Gate Manager LP grew its stake in shares of Bruker by 141.8% during the 2nd quarter. Engineers Gate Manager LP now owns 56,825 shares of the medical research company’s stock valued at $3,420,000 after acquiring an additional 33,329 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new position in shares of Bruker during the 2nd quarter valued at approximately $445,000. Institutional investors own 79.52% of the company’s stock.

Bruker Price Performance

NASDAQ BRKR opened at $60.67 on Monday. The business’s fifty day moving average price is $58.09 and its 200-day moving average price is $49.66. The stock has a market capitalization of $9.24 billion, a price-to-earnings ratio of -86.67, a PEG ratio of 1.71 and a beta of 1.26. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.85 and a quick ratio of 0.92. Bruker has a 1-year low of $30.09 and a 1-year high of $65.30.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.38 by $0.11. The company had revenue of $838.50 million during the quarter, compared to analyst estimates of $853.57 million. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.Bruker’s revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.32 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, equities analysts predict that Bruker will post 2.12 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, September 21st. Bruker’s dividend payout ratio (DPR) is currently -28.57%.

Bruker Company Profile

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.